Mounjaro Measurements Explained: Doses, Pen Sizes and What to Expect

Step 1: Why 2.5 mg is where every course begins

The 2.5 mg starting strength exists for one reason: to let your digestive system adapt. Tirzepatide slows gastric emptying, useful for appetite regulation, but the reason nausea and stomach discomfort are most common in the early weeks. Starting low keeps those effects manageable. The 2.5 mg pen is not intended to produce significant weight change on its own; its job is adjustment, nothing more.

Most people stay at 2.5 mg for four weeks before their prescriber considers moving up. A real clinician reviews your progress at each stage, at nume, that review happens before every repeat order, not automatically. The NHS tirzepatide information page confirms the standard titration schedule and what side effects to monitor during it, which is worth reading alongside your Patient Information Leaflet.

One practical note: what arrives is a plain, unbranded box from DPD, tracked to your door. Inside, the KwikPen is the same at every strength, same device, same injection mechanism, just a different amount of tirzepatide in the cartridge. Each pen contains four doses; one injection per week for the month.

Step 2: The middle measurements, 5 mg through 10 mg

Once tolerance is established, the prescriber can move the dose upward in 2.5 mg increments, typically at four-week intervals. The 5 mg, 7.5 mg and 10 mg strengths are where most of the active weight-loss work happens for the majority of people. SURMOUNT-1 trial data, published in the New England Journal of Medicine, showed meaningful average reductions across all doses above 2.5 mg, with results scaling broadly upward with each strength.

It's worth being clear about what these numbers measure: milligrams of tirzepatide per weekly injection, not a percentage target or a guaranteed outcome. The prescriber is watching for two things at each step, whether the current dose is producing a useful response, and whether side effects are tolerable enough to continue. If neither condition is met in a particular direction, the dose plan changes. This is why the measurements and the clinical review are inseparable.

If you're weighing up the full cost picture at this stage, the Mounjaro weekly payments page sets out how treatment pricing works across dose levels.

Step 3: Higher doses (12.5 mg and 15 mg) and what the trial evidence shows

The 12.5 mg and 15 mg strengths are the upper end of the licensed range. SURMOUNT-1, which followed around 2,500 adults over 72 weeks, recorded average body-weight reductions of roughly 20–21% at 15 mg, figures that represent a meaningful shift in the clinical conversation about what medical weight management can achieve. These are trial averages; individual results vary, and no outcome is guaranteed.

Not everyone needs or reaches 15 mg. The prescriber's aim is the lowest effective dose, the strength that produces a useful response without making side effects difficult to manage. NICE's appraisal of tirzepatide, published as TA1026, notes that treatment should be reviewed if less than 5% weight loss is achieved after six months at the highest tolerated dose. That threshold is measured, which is exactly why the measurement framework matters from week one.

Eligibility for Mounjaro through a private route requires a BMI of 30 or above, or 27 and above if at least one weight-related health condition is present. Lower thresholds apply for some ethnic backgrounds under UK guidance. A prescriber assesses the full clinical picture; a BMI figure alone does not confirm suitability. The Mounjaro overview page covers the licence and eligibility criteria in more detail.

What you cannot adjust yourself, and where to get support

The measurements on the pen are fixed by the licensed schedule; there is no dial to turn. Splitting doses, using more than the prescribed strength, or timing injections differently to the agreed schedule are not things to experiment with. If a dose feels too much or not enough, the answer is a conversation with your prescriber, not a self-directed change.

Questions about which supplements are worth taking alongside Mounjaro come up regularly, particularly around protein and micronutrient intake as appetite falls, and our guide to what supplements to take on Mounjaro is a useful starting point before speaking with your prescriber or a dietitian. For a broader look at how nutrition support fits into the treatment picture, the page covering tirzepatide supplements for weight loss sets out which nutrients tend to need the most attention as your appetite reduces. If you have any other queries about your treatment, the faqs page covers common questions, and the contact page connects you with the aftercare team seven days a week.

If you haven't yet started treatment and want to understand whether Mounjaro is clinically appropriate for you, the right first step is a free consultation with a prescriber who can assess the full picture. Start your free consultation and a GPhC-registered prescriber will review your answers the same day.